SOTERA HEALTH CO
SHCNASDAQTrading Snapshot
- Day Range
- $731.18 β $753.74
- 52-Week Range
- $13.09 β $19.85
- Volume
- $4.64B
- Avg Volume
- $4.47B
- Shares Outstanding
- 285.2M
- Next Earnings
- Nov 25, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.16B
- Last Q Revenue
- $321M
- P/E Ratio
- 32.2
- P/S Ratio
- 4.3x
- EPS (TTM)
- $0.57
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +0.5%
Why Investors Own SHC
- βHigh-growth profile β revenue up +29.9% YoY with expanding US Equity exposure.
- βHealthy economics β 52% gross margin and 24% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
SOTERA HEALTH CO
SHCAbout SOTERA HEALTH CO
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
SOTERA HEALTH CO tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift SHC price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
SOTERA HEALTH CO announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.